BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12592331)

  • 41. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
    Ho CL; Chen YC; Kao WY; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term results of the Japanese Childhood Cancer and Leukemia Study Group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia.
    Tsurusawa M; Shimomura Y; Asami K; Kikuta A; Watanabe A; Horikoshi Y; Matsushita T; Kanegane H; Ohta S; Iwai A; Mugishima H; Koizumi S;
    Leukemia; 2010 Feb; 24(2):335-44. PubMed ID: 20016539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
    Mei YY; Gao C; Cui L; Zhao XX; Zhao W; Li WJ; Wang KL; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Li ZG
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):467-71. PubMed ID: 24120066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic effectiveness of CCLG-97 protocol on standard-risk childhood acute lymphoblastic leukemia].
    Xiao PF; Chai YH; Li JQ; He HL; Wang Y; Li ZP; He YX; Ji ZH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):486-9. PubMed ID: 16083544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
    Toyoda Y; Manabe A; Tsuchida M; Hanada R; Ikuta K; Okimoto Y; Ohara A; Ohkawa Y; Mori T; Ishimoto K; Sato T; Kaneko T; Maeda M; Koike Ki; Shitara T; Hoshi Y; Hosoya R; Tsunematsu Y; Bessho F; Nakazawa S; Saito T
    J Clin Oncol; 2000 Apr; 18(7):1508-16. PubMed ID: 10735899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative program.
    Pacheco C; Lucchini G; Valsecchi MG; Malta A; Conter V; Flores A; Biondi A; Tognoni G; Arguello M; Cavalli F; Silvestri D; Lacayo FB; Masera G
    Pediatr Blood Cancer; 2014 May; 61(5):827-32. PubMed ID: 24376241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study Group.
    Janka-Schaub GE; Harms D; Goebel U; Graubner U; Gutjahr P; Haas RJ; Juergens H; Spaar HJ; Winkler K
    Eur J Pediatr; 1996 Aug; 155(8):640-8. PubMed ID: 8839716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X.
    Pui CH; Simone JV; Hancock ML; Evans WE; Williams DL; Bowman WP; Dahl GV; Dodge RK; Ochs J; Abromowitch M
    Leukemia; 1992 Feb; 6(2):150-7. PubMed ID: 1552746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG).
    Tanimoto M; Miyawaki S; Ino T; Kyo T; Sakamaki H; Naoe T; Hiraoka A; Asou N; Ohshima T; Tsubaki K; Kuriyama K; Ueda T; Minamil S; Okabe K; Saito H; Murakami H; Hirano M; Dohy H; Onozawa Y; Suzuki H; Ohno R
    Int J Hematol; 1998 Dec; 68(4):421-9. PubMed ID: 9885441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy and prognosis analysis in 188 children with acute lymphoblastic leukemia of China].
    Yang MH; Jia WG; Cao LZ; He YL; Liao N; Chen GL; Luo JM; Xu WQ; Yang J
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):498-501. PubMed ID: 19099804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia].
    Tang JY; Xue HL; Gu LJ; Chen J; Pan C; Chen J; Wang YP; Ye H; Dong L; Zou JY
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):490-3. PubMed ID: 16083545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI.
    Wheeler KA; Richards SM; Bailey CC; Gibson B; Hann IM; Hill FG; Chessells JM
    Blood; 2000 Oct; 96(7):2412-8. PubMed ID: 11001892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy.
    Rivera GK; Raimondi SC; Hancock ML; Behm FG; Pui CH; Abromowitch M; Mirro J; Ochs JS; Look AT; Williams DL
    Lancet; 1991 Jan; 337(8733):61-6. PubMed ID: 1670723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term efficacy of CAMSBDH-ALL chemotherapy protocol for the treatment of childhood acute lymphoblastic leukemia].
    Chen XJ; Zou Y; Chen YM; Yang WY; Wang SC; Guo Y; Zhang L; Ruan M; Liu XM; Liu F; Liu TF; Zhang JY; Qi BQ; Chang LX; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1019-24. PubMed ID: 25344183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group.
    Liang DC; Hung IJ; Yang CP; Lin KH; Chen JS; Hsiao TC; Chang TT; Pui CH; Lee CH; Lin KS
    Leukemia; 1999 Feb; 13(2):155-60. PubMed ID: 10025887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term follow-up of childhood low-risk ALL patients treated with SCMC-ALL-2005 protocol].
    Hu WT; Xue HL; Chen J; Pan C; Shen SH; Zhou M; Ye QD; Jiang H; Luo CY; Tang YJ; Wang JM; Gu LJ; Tang JY
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):834-8. PubMed ID: 24171955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
    Manabe A; Tsuchida M; Hanada R; Ikuta K; Toyoda Y; Okimoto Y; Ishimoto K; Okawa H; Ohara A; Kaneko T; Koike K; Sato T; Sugita K; Bessho F; Hoshi Y; Maeda M; Kinoshita A; Saito T; Tsunematsu Y; Nakazawa S
    J Clin Oncol; 2001 Jul; 19(13):3182-7. PubMed ID: 11432884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study.
    Li CK; Chik KW; Ha SY; Lee AC; Yuen HL; Ling SC; Lee V; Chan GC; Shing MM; Chan LC; Ng MH
    Hong Kong Med J; 2006 Feb; 12(1):33-9. PubMed ID: 16495587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.